Jacob Allan Udell

BSc (York University/Harvard)
MD (University of Toronto)
MPH (Harvard)

Research Interests

Dr. Udell’s research is focused on novel cardiovascular risk factor identification and strategies to reduce risk, such as influenza vaccination, as well as unique risk factors in women. He is a co-PI of the NHLBI-sponsored INVESTED multicentre randomized trial comparing two strategies of influenza vaccine to reduce death or cardiopulmonary hospitalizations in high risk cardiovascular patients.

Professional Interests

Primary and secondary cardiovascular prevention
Influenza
Acute myocardial infarction
Heart failure with preserved ejection fraction
Diabetes and heart failure
Randomized registry trials
Comparative effectiveness

Impact

His work on innovative cardiovascular risk factor identification and therapy has led to: clinical trial and outcomes publications in the New England Journal of Medicine, JAMA, and JACC; and alterations in national practice guidelines. He is the PI on a number of grants investigating primary and secondary cardiovascular prevention and is a recipient of a 2014 CIHR Health Services and Policy Research Rising Star Award, a 2015 Canadian Pacific Has Heart Cardiovascular Award and 2016 National New Investigator/Ontario Clinician Scientist (Phase I) Award from the Heart and Stroke Foundation of Canada, and a 2016 Ontario Ministry of Research and Innovation Early Researcher Award.

Other Affiliations

Assistant Professor, Faculty of Medicine, University of Toronto
Scientist, Women’s College Research Institute
Adjunct Scientist, Institute of Clinical Evaluative Sciences
Cardiologist, Women’s College Hospital and University Health Network

Publications

PubMed